Literature DB >> 10980852

Redefining the role of antiarrhythmic drugs in the management of ventricular arrhythmias.

D Mehta1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10980852     DOI: 10.1007/s11886-999-0048-2

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  14 in total

1.  Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.

Authors:  A Pacifico; S H Hohnloser; J H Williams; B Tao; S Saksena; P D Henry; E N Prystowsky
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

2.  Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study).

Authors: 
Journal:  Am J Cardiol       Date:  1991-03-15       Impact factor: 2.778

3.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

4.  Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.

Authors:  W Haverkamp; A Martinez-Rubio; C Hief; A Lammers; S Mühlenkamp; T Wichter; G Breithardt; M Borggrefe
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

Review 5.  The role of intravenous amiodarone in the management of cardiac arrhythmias.

Authors:  A D Desai; S Chun; R J Sung
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

6.  Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction.

Authors:  W G Stevenson; H Khan; P Sager; L A Saxon; H R Middlekauff; P D Natterson; I Wiener
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

Review 7.  Proarrhythmia.

Authors:  P L Friedman; W G Stevenson
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

8.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

9.  Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator.

Authors:  K Seidl; B Hauer; N G Schwick; R Zahn; J Senges
Journal:  Am J Cardiol       Date:  1998-09-15       Impact factor: 2.778

10.  Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. The ESVEM Investigators.

Authors: 
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.